Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry.

Hee Soon ParkYoung-Hoon KimJune Soo KimYong-Seog OhDong-Gu ShinHui-Nam PakGyo-Seung HwangKee-Joon ChoiSeil OhJin-Bae KimMan-Young LeeHyung-Wook ParkDae-Kyeong KimEun-Sun JinJae-Seok ParkIl-Young OhDae-Hee ShinHyoung-Seob ParkJun Hyung KimNam-Ho KimMin-Soo AhnBo-Jeong SeoYoung-Joo KimSeongsik KangJuneyoung Lee

Published in: Journal of arrhythmia (2019)

The conditions of NVAF patients were inadequately controlled with VKA with or without an APL. These findings suggest that other antithrombotic treatment options are warranted in NVAF patients to achieve INR control.

Keyphrases

atrial fibrillation
end stage renal disease
antiplatelet therapy
ejection fraction
newly diagnosed
chronic kidney disease
percutaneous coronary intervention
prognostic factors
heart failure
left atrial appendage
mitral valve
venous thromboembolism
patient reported